[
    {
        "text": "I hereby certify that the correspondence to which this certificate is affixed, including each document referred to therein as being enclosed or submitted therewith, is being deposited with the United States Postal Service with sufficient postage as first class mail addressed to the Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450 on\n\n\nDate 7-18-05\n\nIN THE UNITED STATES PATENT AND TRADEMARK OFFICE\n\nInventor(s): Kirvin L. Hodge, et al. Atty. Ref.: 18030-PCTUS\nAppl. No.: 10/531,630 Group Art Unit:\nFiled:\nApril 14, 2005\nExaminer:\nFor: COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS\n\nCommissioner for Patents\nP.O. Box 1450\n\nAlexandria, VA 22313-1450\nSir:\n\nINFORMATION DISCLOSURE STATEMENT\n\nPursuant to 37 CFR 1.56, 1.97 and 1.98, the attention of the Examiner is directed to the documents listed on the enclosed Form PTO-1449. A copy of each listed document is enclosed.\n\nIn addition, applicants enclose an International Search Report, dated October 15, 2004, in connection with corresponding International Patent Application No. PCT/US04/03718. Each of the documents listed in the Search Report is listed in the Form PTO-1449 enclosed herewith.",
        "page_idx": 0
    },
    {
        "text": "Inventor(s): Hodge, et al.\nApplication No.: 10/531,630\nPage 2\nEach of the documents WO 99/11255 and WO 99/19291, which are not in the English language, either contains or is accompanied by an English language abstract.\n\nIt is believed that no fee is required in connection with the filing of this Statement. If any fee is required, the Commissioner is hereby authorized to charge the amount of such fee to Deposit Account No. 50-1677.\n\nRespectfully submitted,\n\n\nReg. No. 38522\nAttorney for Applicant(s)\n930 Clopper Road\nGaithersburg, MD 20878\nPhone: (240) 631-2500 x3276\nFacsimile: (240) 683-3794",
        "page_idx": 1
    },
    {
        "text": "",
        "page_idx": 2
    },
    {
        "text": "\\begin{tabular}{|c|c|c|c|c|c|}\n  \\multicolumn{3}{|l|}{\\multirow[t]{2}{*}{Substitute for form 1449/PTO}} & & \\multicolumn{2}{|r|}{Complete if Known} \\\\\n  & & & & Application Number & 10/531,630 \\\\\n  \\multicolumn{4}{|l|}{\\multirow[t]{2}{*}{INFORMATION DISCLOSURE STATEMENT BY APPLICANT}} & Filing Date & April 14, 2005 \\\\\n  & & & & First Named Inventor & Kirvin L. Hodge \\\\\n  \\multicolumn{4}{|r|}{\\multirow[t]{2}{*}{(Use as many sheets as necessary)}} & Art Unit & Not Assigned \\\\\n  & & & & Examiner Name & Not Assigned \\\\\n  Sheet & 2 & of & 2 & Attorney Docket Number & 18030-PCTUS \\\\\n \n\\end{tabular}\n\\begin{tabular}{|c|c|c|c|}\n  \\multicolumn{4}{|c|}{NON PATENT LITERATURE DOCUMENTS} \\\\\n  Examiner Initials* & $$\\begin{aligned} \\text { Cite } \\text { No. }$$ Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item (book, magazine, journal, serial, symposium, catalog, etc.), date, page(s), volume-issue number(s), publisher, city and/or country where published. $\\mathrm{T}^{2}$  Chemical Abstract DN:128:154084, corresponding to Momose, et al. WO98/03505. See compound RN 152380-68-2.   Chemical Abstract DN: 130: 237567, corresponding to Tajima, et al. WO99/11255. See compounds RN 221258-65-7, 221258-68-0, 221261-93-4, and 221262-95-6.   Chemical Abstract DN: 130:281874, corresponding to Shoda, et al. WO99/19291. See compounds RN 222627-31-8 and 222627-32-9.   Chemical Abstract DN: 65:20620, corresponding to Carlo, BE 667498. See compound RN 6686-26-6.                   \\end{tabular}\nExaminer  Date Signature Considered\n*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through citation if not in conformance and not considered. Include copy of this form with next communication to applicant.\n1 Applicant's unique citation designation number (optional). 2 Applicant is to place a check mark here if English language Translation is attached.\nThis collection of information is required by 37 CFR 1.98. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 2 hours to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria; VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO:\nCommissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.",
        "page_idx": 3
    }
]